Novel Molecularly Targeted Therapies and Biomarkers in Advanced Colorectal Cancer

Treatment of metastatic colorectal cancer has continued to evolve over the last several years, with emerging identification of biomarkers that underlie heterogeneity of responses to new and existing therapy. Ongoing clinical research seeks to identify new therapeutic options in molecularly-defined subgroups of patients. We will review the most exciting and clinically impactful research findings in this presentation.

Course summary
Available credit: 
  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Course opens: 
08/10/2021
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 Participation

    UNC Lineberger Cancer Network certificate of participation.

    Tim Poe, Director of Telehealth

Price

Cost:
$0.00
Please login or register to take this course.